Condition: Polysubstance Abuse · Opioid Use · Tobacco Use · Sponsor: Rutgers, The State University of New Jersey
The purpose of this study is to 1) examine barriers and facilitators to implementation of MI and MORE for polysubstance use and evaluate strategies for optimizing training, fidelity, and clinic uptake, and 2) evaluate patient outcomes related to the effectiveness of MORE decreasing opioid, tobacco, and other drug use.
This description comes directly from the study's public registry record.
Nina Cooperman, PsyD · 732-235-8569 · cooperna@rwjms.rutgers.edu
Eric Garland, PhD · 801-581-3826 · eric.garland@socwk.utah.edu
Always discuss trial participation with your own doctor first.
| Rutgers Robert Wood Johnson Medical School | New Brunswick, New Jersey, United States | Recruiting |
| University of Utah | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06033599